Ledger.Open graph →
SEC Form D · filed October 15, 2024

Cirius Therapeutics, Inc

Offering
$1.6M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GRAND RAPIDS, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Robert Beardsley · University City, MOExecSkot R. Welch · GRAND RAPIDS, MIExec · DirectorDavid Van Andel · Grand Rapids, MIDirectorMichael Jandernoa · Grand Rapids, MIDirectorMark Olesnavage · Grand Rapids, MIExecRobert Beardsley · University City, MOExecJerry Callahan · Grand Rapids, MIExecRobert Zerbe · Grand Rapids, MIDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗